312 related articles for article (PubMed ID: 30694076)
1. Glycemic Variability: Risk Factors, Assessment, and Control.
Kovatchev B
J Diabetes Sci Technol; 2019 Jul; 13(4):627-635. PubMed ID: 30694076
[TBL] [Abstract][Full Text] [Related]
2. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
Rodbard D
Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
[TBL] [Abstract][Full Text] [Related]
3. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
[TBL] [Abstract][Full Text] [Related]
4. Glucose Variability: A Review of Clinical Applications and Research Developments.
Rodbard D
Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
[TBL] [Abstract][Full Text] [Related]
5. A View Beyond HbA1c: Role of Continuous Glucose Monitoring.
Chehregosha H; Khamseh ME; Malek M; Hosseinpanah F; Ismail-Beigi F
Diabetes Ther; 2019 Jun; 10(3):853-863. PubMed ID: 31037553
[TBL] [Abstract][Full Text] [Related]
6. Metrics for glycaemic control - from HbA
Kovatchev BP
Nat Rev Endocrinol; 2017 Jul; 13(7):425-436. PubMed ID: 28304392
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Physical Activity on Glycemic Variability Assessed by Continuous Glucose Monitoring in Patients With Type 2 Diabetes Mellitus: A Systematic Review.
Bennetsen SL; Feineis CS; Legaard GE; Lyngbæk MPP; Karstoft K; Ried-Larsen M
Front Endocrinol (Lausanne); 2020; 11():486. PubMed ID: 32903679
[No Abstract] [Full Text] [Related]
8. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
Foreman YD; Brouwers MCGJ; van der Kallen CJH; Pagen DME; van Greevenbroek MMJ; Henry RMA; Koster A; Wesselius A; Schaper NC; Stehouwer CDA
Diabetes Technol Ther; 2020 May; 22(5):395-403. PubMed ID: 31886732
[No Abstract] [Full Text] [Related]
9. Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes.
Kovatchev B; Cobelli C
Diabetes Care; 2016 Apr; 39(4):502-10. PubMed ID: 27208366
[TBL] [Abstract][Full Text] [Related]
10. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
11. CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review.
Breyton AE; Lambert-Porcheron S; Laville M; Vinoy S; Nazare JA
Front Endocrinol (Lausanne); 2021; 12():666008. PubMed ID: 34566883
[TBL] [Abstract][Full Text] [Related]
12. Continuous glucose monitoring to assess glycemic control in the first 6 weeks after pancreas transplantation.
Dadlani V; Kaur RJ; Stegall M; Xyda SE; Kumari K; Bonner K; Smith B; Thapa P; Dean PG; Kudva YC
Clin Transplant; 2019 Oct; 33(10):e13719. PubMed ID: 31545535
[TBL] [Abstract][Full Text] [Related]
13. How Should We Assess Glycemic Variability in Type 1 Diabetes? Contribution of Principal Component Analysis for Interstitial Glucose Indices in 142 Children.
Guilmin-Crépon S; Carel JC; Schroedt J; Scornet E; Alberti C; Tubiana-Rufi N
Diabetes Technol Ther; 2018 Jun; 20(6):440-447. PubMed ID: 29923773
[TBL] [Abstract][Full Text] [Related]
14. Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study.
Nusca A; Lauria Pantano A; Melfi R; Proscia C; Maddaloni E; Contuzzi R; Mangiacapra F; Palermo A; Manfrini S; Pozzilli P; Di Sciascio G
J Diabetes Res; 2015; 2015():250201. PubMed ID: 26273664
[TBL] [Abstract][Full Text] [Related]
15. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
[TBL] [Abstract][Full Text] [Related]
16. The application of simple metrics in the assessment of glycaemic variability.
Monnier L; Colette C; Owens DR
Diabetes Metab; 2018 Sep; 44(4):313-319. PubMed ID: 29602622
[TBL] [Abstract][Full Text] [Related]
17. Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care.
Wilmot EG; Choudhary P; Leelarathna L; Baxter M
Diabetes Obes Metab; 2019 Dec; 21(12):2599-2608. PubMed ID: 31364268
[TBL] [Abstract][Full Text] [Related]
18. Analytical methods for the retrieval and interpretation of continuous glucose monitoring data in diabetes.
Kovatchev B; Breton M; Clarke W
Methods Enzymol; 2009; 454():69-86. PubMed ID: 19216923
[TBL] [Abstract][Full Text] [Related]
19. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
Kropff J; DeVries JH
Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
[TBL] [Abstract][Full Text] [Related]
20. Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data.
Garcia A; Balo AK; Buckingham BA; Hirsch IB; Peyser TA
Diabetes Technol Ther; 2017 Dec; 19(12):699-706. PubMed ID: 29243959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
